Shield Therapeutics plc (AIM:STX)

London · Delayed Price · Currency is GBP · Price in GBX

3.950

-0.450 (-10.23%)

Jul 31, 2026, 5:06 PM GMT

Shield Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	11.62	6.52	13.95	3.4	16.35
Cash & Short-Term Investments	11.62	6.52	13.95	3.4	16.35
Cash Growth	78.13%	-53.23%	309.99%	-79.19%	306.64%
Accounts Receivable	24.28	24.97	13.5	6.49	3.95
Inventory	9.21	5.66	3.2	1.76	2.21
Other Current Assets	0.11	0.79	0.61	0.53	0.78
Total Current Assets	45.22	37.94	31.26	12.17	23.28
Net Property, Plant & Equipment	0.11	0.37	0.67	0.24	0.41
Other Intangible Assets	18.89	18.17	16.86	14.21	36.22
Other Long-Term Assets	1	1	-	-	-
Total Assets	65.22	57.48	48.8	26.62	59.91

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	37.43	23.19	12.72	11.44	4.2
Current Portion of Leases	-	0.2	0.21	0.11	0.21
Other Current Liabilities	12.73	9.24	0.8	1.28	0.15
Total Current Liabilities	50.16	32.62	13.74	12.83	4.56
Long-Term Debt	30.14	26.17	19.84	6.68	-
Long-Term Leases	-	-	0.2	-	-
Other Long-Term Liabilities	-	-	-	0.56	-
Total Long-Term Liabilities	30.14	26.17	20.03	7.25	-
Total Liabilities	80.29	58.8	33.77	20.07	4.56

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	20.44	19.91	15.01	5.37	4.57
Additional Paid-in Capital	247.95	246.43	242	212.62	210.66
Accumulated Other Comprehensive Income	-6.75	-7.81	-8.45	-10.34	-7.66
Retained Earnings	-276.71	-259.85	-233.53	-201.11	-152.23
Shareholders' Equity	-15.08	-1.32	15.03	6.54	55.35
Total Liabilities & Equity	65.22	57.48	48.8	26.62	59.91

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	30.14	26.37	20.25	6.79	0.21
Net Cash (Debt)	-18.51	-19.85	-6.3	-3.39	16.14
Net Cash Growth	-	-	-	-	305.27%
Net Cash Per Share	-0.02	-0.03	-0.01	-0.01	0.08
Book Value	-15.08	-1.32	15.03	6.54	55.35
Book Value Per Share	-0.01	-0.00	0.02	0.03	0.27
Tangible Book Value	-33.96	-19.49	-1.83	-7.66	19.13
Tangible Book Value Per Share	-0.03	-0.02	-0.00	-0.03	0.09